Not Available

Not AvailableThe study was to examine the effects of dietary L. aspera on growth performance, physio-metabolic response and health status of Rita rita fish reared in tanks for 60 days. Six experimental diets were formulated containing 0 g/kg, 3 g/kg, 6 g/kg, 9 g/kg and 12 g/kg L. aspera and designated as D0, D3, D6, D9 and D12 respectively. The inclusion of L. aspera at graded levels resulted in significantly varying effects on growth performance where the weight gain (%), specific growth rate (SGR) and feed conversion efficiency (FCE) were significantly higher (p<0.05) in D6 and D9 groups than others. The protease and amylase activities were elevated in L. aspera supplemented groups than the control group (p<0.05), whereas lactate dehydrogenase, malate dehydrogenase and serum transaminase enzyme activities were significantly reduced with the increasing level of L. aspera and comparatively higher activities of the respective enzymes were found in the control group. The activities of oxidative stress enzymes were significantly higher (p<0.05) in the D9 group and lower in control. The blood glucose level significantly decreased with the increasing level of L. aspera in the experimental diets. The L. aspera supplemented fish had significantly higher liver glycogen, serum protein, albumin and globulin than control group. Red blood cell count was significantly higher (p<0.05) in D6-D12, whereas white blood cell count and haemoglobin content were significantly higher (p<0.05) in D6 and D9 groups. Regression analysis showed that L. aspera at the level of 7.3–7.9 g/kg is optimum for better growth and feed efficiency.Not Availabl

Detailed Analysis of Gene Polymorphisms Associated with Ischemic Stroke in South Asians

The burden of stroke is disproportionately high in the South Asian subcontinent with South Asian ethnicity conferring a greater risk of ischemic stroke than European ancestry regardless of country inhabited. While genes associated with stroke in European populations have been investigated, they remain largely unknown in South Asians. We conducted a comprehensive meta-analysis of known genetic polymorphisms associated with South Asian ischemic stroke, and compared effect size of the MTHFR C677T-stroke association with effect sizes predicted from homocysteine-stroke association. Electronic databases were searched up to August 2012 for published case control studies investigating genetic polymorphisms associated with ischemic stroke in South Asians. Pooled odds ratios (OR) for each gene-disease association were calculated using a random-effects model. We identified 26 studies (approximately 2529 stroke cases and 2881 controls) interrogating 33 independent genetic polymorphisms in 22 genes. Ten studies described MTHFR C677T (108 with TT genotype and 2018 with CC genotype) -homocysteine relationship and six studies (735 stroke cases and 713 controls) described homocysteine-ischemic stroke relationship. Risk association ORs were calculated for ACE I/D (OR 5.00; 95% CI, 1.17–21.37; p = 0.03), PDE4D SNP 83 (OR 2.20; 95% CI 1.21–3.99; p = 0.01), PDE4D SNP 32 (OR 1.57; 95% CI 1.01–2.45, p = 0.045) and IL10 G1082A (OR 1.44; 95% CI, 1.09–1.91, p = 0.01). Significant association was observed between elevated plasma homocysteine levels and MTHFR/677 TT genotypes in healthy South Asians (Mean difference (ΔX) 5.18 µmol/L; 95% CI 2.03–8.34: p = 0.001). Our results demonstrate that the genetic etiology of ischemic stroke in South Asians is broadly similar to the risk conferred in Europeans, although the dataset is considerably smaller and warrants the same clinical considerations for risk profiling